Gavin Giovannoni

InstitutionQueen Mary University of London
AddressLondon
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 2 publications in June 2021
    All Publications
    Bar chart showing 517 publications over 26 distinct years, with a maximum of 48 publications in 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Yeh EA, Baker D. COVID-19 vaccines and multiple sclerosis disease-modifying therapies. Mult Scler Relat Disord. 2021 08; 53:103155. PMID: 34358943.
      Citations:    Fields:    Translation:Humans
    2. Grisold W, Moro E, Teresa Ferretti M, Hege Aamodt A, Arabia G, Lebedeva ER, Carvalho V, Rakusa M, Vonck K, Aybeck S, Hassan Mansour A, Goudier R, Giovannoni G, Jaarsma J, Judit Molnar M, Matczack M, Bassetti C, de Visser M. Gender issues during the times of COVID-19 pandemic. Eur J Neurol. 2021 Oct; 28(10):e73-e77. PMID: 33751757.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Reyes S, Cunningham AL, Kalincik T, Havrdová EK, Isobe N, Pakpoor J, Airas L, Bunyan RF, van der Walt A, Oh J, Mathews J, Mateen FJ, Giovannoni G. Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement. J Neuroimmunol. 2021 08 15; 357:577627. PMID: 34139567.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    4. Allen-Philbey K, Stennett A, Begum T, Johnson AC, Dobson R, Giovannoni G, Gnanapavan S, Marta M, Smets I, Turner BP, Baker D, Mathews J, Schmierer K. Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis. Mult Scler Relat Disord. 2021 Jul; 52:103028. PMID: 34049216.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    5. Vishnevetsky A, Hawkes C, Lechner-Scott J, Giovannoni G, Levy M, Pohl D. B cell therapy and the use of RNA-based COVID-19 vaccines. Mult Scler Relat Disord. 2021 04; 49:102887. PMID: 33883063.
      Citations:    Fields:    Translation:HumansCells
    6. Baker D, Roberts CAK, Pryce G, Kang AS, Marta M, Reyes S, Schmierer K, Giovannoni G, Amor S. COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases. Clin Exp Immunol. 2020 11; 202(2):149-161. PMID: 32671831.
      Citations: 48     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    7. Salama S, Giovannoni G, Hawkes CH, Lechner-Scott J, Waubant E, Levy M. Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler Relat Disord. 2020 07; 42:102259. PMID: 32571580.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    8. Baker D, Amor S, Kang AS, Schmierer K, Giovannoni G. The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic. Mult Scler Relat Disord. 2020 Aug; 43:102174. PMID: 32464584.
      Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
    9. Giovannoni G. Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19. Mult Scler Relat Disord. 2020 06; 41:102135. PMID: 32339915.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    10. Giovannoni G, Hawkes C, Lechner-Scott J, Levy M, Waubant E, Gold J. The COVID-19 pandemic and the use of MS disease-modifying therapies. Mult Scler Relat Disord. 2020 04; 39:102073. PMID: 32334820.
      Citations: 79     Fields:    Translation:HumansCellsPHPublic Health